Chronic Hepatitis

Infectious Disease·MeSH: Hepatitis, Chronic

58 drugs in development·20 companies·1 clinical trial

Drug Pipeline by Phase

Approved(6)

Drug	Company
huoliyuan	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
mavyret	AbbVie Inc. (ABBV)
MAVYRET / MAVIRET	ENANTA PHARMACEUTICALS INC (ENTA)
MAVYRET® / MAVIRET® (glecaprevir/pibrentasvir)	ENANTA PHARMACEUTICALS INC (ENTA)
promacta	Novartis AG (NVS)
xin ao xing oleanolic acid	BIOSTAR PHARMACEUTICALS, INC. (BSPM)

Phase 3(5)

Drug	Company
brelovitug	Mirum Pharmaceuticals, Inc. (MIRM)
bulevirtide	Mirum Pharmaceuticals, Inc. (MIRM)
delayed treatment with brelovitug	Mirum Pharmaceuticals, Inc. (MIRM)
libevitug	China Health Industries Holdings, Inc. (CHHE)
na therapy	POINT Biopharma Global Inc. (PNT)

Phase 2(31)

Drug	Company
ab-729	Arbutus Biopharma Corp (ABUS)
ALG-000184	Aligos Therapeutics, Inc. (ALGS)
ARC-520 Injection	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
bemnifosbuvir	Atea Pharmaceuticals, Inc. (AVIR)
Bemnifosbuvir	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
bepirovirsen	IONIS PHARMACEUTICALS INC (IONS)
chadox1-hbv	Barinthus Biotherapeutics plc. (BRNS)
daplusiran/tomligisiran	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
entecavir	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
hepatitis b vaccine	POINT Biopharma Global Inc. (PNT)
hh-003	China Health Industries Holdings, Inc. (CHHE)
imdusiran	Arbutus Biopharma Corp (ABUS)
imdusiran (AB-729)	Arbutus Biopharma Corp (ABUS)
mva-hbv	Barinthus Biotherapeutics plc. (BRNS)
nas	POINT Biopharma Global Inc. (PNT)
nucleoside analogs	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
peg-ifn	POINT Biopharma Global Inc. (PNT)
Peg-IFNα-2a	Arbutus Biopharma Corp (ABUS)
pegylated interferon-alfa 2a	Vir Biotechnology, Inc. (VIR)
pevifoscorvir	Aligos Therapeutics, Inc. (ALGS)
rg6346	Dicerna Pharmaceuticals Inc (DRNA)
ruzasvir	Atea Pharmaceuticals, Inc. (AVIR)
Ruzasvir	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
selgantolimod	GILEAD SCIENCES, INC. (GILD)
taf	China Health Industries Holdings, Inc. (CHHE)
tdf	Aligos Therapeutics, Inc. (ALGS)
tenofovir alafenamide	GILEAD SCIENCES, INC. (GILD)
tqa3334	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
vir-2218	GILEAD SCIENCES, INC. (GILD)
vir-2218	Vir Biotechnology, Inc. (VIR)
VTP-300	Barinthus Biotherapeutics plc. (BRNS)

Phase 1(12)

Drug	Company
AB-101	Arbutus Biopharma Corp (ABUS)
ABI-4334 (4334)	ASSEMBLY BIOSCIENCES, INC. (ASMB)
ahb-137	POINT Biopharma Global Inc. (PNT)
ahb-171	POINT Biopharma Global Inc. (PNT)
ALG-001075	Aligos Therapeutics, Inc. (ALGS)
ALG-125755	Aligos Therapeutics, Inc. (ALGS)
diphenhydramine	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
EDP-514	ENANTA PHARMACEUTICALS INC (ENTA)
IMC-I109V	Immunocore Holdings plc (IMCR)
nucleoside analogue	POINT Biopharma Global Inc. (PNT)
Nucleoside Analogue	Arbutus Biopharma Corp (ABUS)
tenofovir	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Preclinical(2)

Drug	Company
alvr107	Kalaris Therapeutics, Inc. (KLRS)
at-587	Atea Pharmaceuticals, Inc. (AVIR)

BLA Filed(1)

Drug	Company
bulevirtide	GILEAD SCIENCES, INC. (GILD)

Phase 4(1)

Drug	Company
Vemlidy	Arbutus Biopharma Corp (ABUS)

BioSniper tracks 58 drugs in development for Chronic Hepatitis across 20 companies.

There are 1 clinical trial targeting Chronic Hepatitis tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.